Advancements and challenges in pheochromocytoma and paraganglioma research: a collection of insights

in Endocrine-Related Cancer
Authors:
Judith Favier Université Paris Cité, Inserm UMR970 PARCC, Equipe Labellisée par la Ligue contre le cancer, Paris, France

Search for other papers by Judith Favier in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0001-8190-5853
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-3541-3767
, and
Roderick Clifton-Bligh Department of Endocrinology Royal North Shore Hospital, University of Sydney, Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-1545-0368

Correspondence should be addressed to J Favier: judith.favier@inserm.fr

This editorial accompanies a themed collection on Advances and Future Directions in Pheochromocytoma and Paraganglioma. The collection editors for this collection were Judith Favier (Paris Cardiovascular Research Center, France), Karel Pacak (NICHHD, USA) and Roderick Clifton-Bligh (University of Sydney, Australia).

DOI:
https://doi.org/10.1530/ERC-24-0050
Volume/Issue:
Volume 31: Issue 8
Article Type:
Editorial
Article ID:
e240050
Online Publication Date:
12 Jun 2024
Copyright:
© the author(s) 2024
Restricted access
Rent on DeepDyve

Sign up for journal news

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 110 110 4
PDF Downloads 168 168 2

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Copyright:
© the author(s) 2024
Article ID:
e240050
Received Date:
07 Mar 2024
Accepted Date:
17 May 2024
Print Publication Date:
01 Aug 2024
Online Publication Date:
12 Jun 2024

  • Amore F, Garella R, Santi A, Guasti D, Martinelli S, Canu L, Bani D, Neuzil J, Maggi M, Squecco R, et al.2023 The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide. Endocrine-Related Cancer 30 e230167. (https://doi.org/10.1530/ERC-23-0167)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Davidoff DF, Lim ES, Benn DE, Subramaniam Y, Dorman E, Burgess JR, Akker SA & & Clifton-Bligh RJ 2023 Distortion in transmission of pathogenic SDHB- and SDHD-mutated alleles from parent to offspring. Endocrine-Related Cancer 30 e220233. (https://doi.org/10.1530/ERC-22-0233)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Gimenez-Roqueplo A-P, Robledo M & & Dahia PLM 2023 Update on the genetics of paragangliomas. Endocrine-Related Cancer 30 e220373. (https://doi.org/10.1530/ERC-22-0373)

  • Loughrey PB, Roncaroli F, Healy E, Weir P, Basetti M, Casey RT, Hunter SJ & & Korbonits M 2022 Succinate dehydrogenas e and MYC-associated factor X mutations in pituitary neuroendocrine tumours. Endocrine-Related Cancer 29 R157–R172. (https://doi.org/10.1530/ERC-22-0157)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Pacak K & & Clifton-Bligh R 2023 International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes. Endocrine-Related Cancer 30 e230030. (https://doi.org/10.1530/ERC-23-0030)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Richter S, Garrett TJ, Bechmann N, Clifton-Bligh RJ & & Ghayee HK 2023 Metabolomics in paraganglioma: applications and perspectives from genetics to therapy. Endocrine-Related Cancer 30 e220376. (https://doi.org/10.1530/ERC-22-0376)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Rosenblum JS, Wang H, Nazari MA, Zhuang Z & & Pacak K 2023 Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes. Endocrine-Related Cancer 30 e230050. (https://doi.org/10.1530/ERC-23-0050)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Schürfeld R, Pamporaki C, Peitzsch M, Rayes N, Sabri O, Rohm S, Biemann R, Sandner B, Tönjes A & & Eisenhofer G 2024 False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade. Endocrine-Related Cancer 31 e230063. (https://doi.org/10.1530/ERC-23-0063)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Taïeb D, Fargette C, Jha A & & Pacak K 2023 Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine. Endocrine-Related Cancer 30 e220375. (https://doi.org/10.1530/ERC-22-0375)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Tischler AS & & Favier J 2023 Progress and challenges in experimental models for pheochromocytoma and paraganglioma. Endocrine-Related Cancer 30 e220405. (https://doi.org/10.1530/ERC-22-0405)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zhang L, Åkerström T, Mollazadegan K, Beuschlein F, Pacak K, Skogseid B & & Crona J 2023 Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma. Endocrine-Related Cancer 30 e220354. (https://doi.org/10.1530/ERC-22-0354)

    • PubMed
    • Search Google Scholar
    • Export Citation